ASHLEY HILBURN: Open Payments
NPI 1265996995 · LAMAR, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$540 in 30 payments from 11 companies in 2025. Trend: 2023 $482 · 2024 $510 · 2025 $540
Food & beverage: $540
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $154 |
| AstraZeneca Pharmaceuticals LP | 4 | $77 |
| ABBVIE INC. | 3 | $55 |
| Abbott Laboratories | 3 | $50 |
| Lilly USA, LLC | 3 | $43 |
| Exact Sciences Corporation | 2 | $36 |
| SHIELD THERAPEUTICS INC | 2 | $34 |
| INTUITIVE SURGICAL, INC. | 1 | $33 |
| Dexcom, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $18 |
Products named: Ozempic, VRAYLAR, Wegovy, FREESTYLE LIBRE 3, MOUNJARO, FARXIGA, Cologuard Collection Kit, ACCRUFER.
Industry payments across SC — which companies pay providers there.
